Royalty Pharma PLC
XBER:RPD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Royalty Pharma PLC
XBER:RPD
|
US |
|
I
|
Inovio Pharmaceuticals Inc
F:GBMB
|
US |
|
G
|
GAIL (India) Ltd
BSE:532155
|
IN |
|
G
|
Genworth Financial Inc
BMV:GNW
|
US |
|
M
|
MDU Resources Group Inc
F:MRE
|
US |
|
Catena AB
F:T9R
|
SE |
|
S
|
Shanghai Electric Group Co Ltd
XMUN:USR
|
CN |
|
P
|
Perenti Global Ltd
OTC:AUSDF
|
AU |
|
H
|
Heritage Global Inc
NASDAQ:HGBL
|
US |
|
Nedap NV
AEX:NEDAP
|
NL |
|
A
|
Abliva AB
F:NTP
|
SE |
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
US |
|
C
|
Chart Industries Inc
F:I3N
|
US |
|
A
|
aTyr Pharma Inc
SWB:471A
|
US |
|
R
|
Ramaco Resources Inc
NASDAQ:METCB
|
US |
Wall St Price Targets
RPD Price Targets Summary
Royalty Pharma PLC
According to Wall Street analysts, the average 1-year price target for RPD is 40.71 EUR with a low forecast of 32.4 EUR and a high forecast of 48.33 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RPD's stock price target?
Price Target
40.71
EUR
According to Wall Street analysts, the average 1-year price target for RPD is 40.71 EUR with a low forecast of 32.4 EUR and a high forecast of 48.33 EUR.
What is the Revenue forecast for Royalty Pharma PLC?
Projected CAGR
18%
Over the last 7 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 18%.
What is the Operating Income forecast for Royalty Pharma PLC?
Projected CAGR
12%
Over the last 7 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 12%.
What is the Pre-Tax Income forecast for Royalty Pharma PLC?
Projected CAGR
37%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been -2%. The projected CAGR for the next 3 years is 37%.
What is the Net Income forecast for Royalty Pharma PLC?
Projected CAGR
63%
Over the last 7 years, the compound annual growth rate for Net Income has been -8%. The projected CAGR for the next 3 years is 63%.
